Dexmedetomidine in Pediatric Tonsillectomy

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The hypothesis of this study is that the administration of an intra-operative dose of dexmedetomidine will result in adequate analgesia without respiratory depression thereby resulting in an early discharge from the post anesthetic care unit following adenotonsillectomy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Baylor College of Medicine
• Treatments: Dexmedetomidine; Morphine

Criteria

Inclusion Criteria:

• Children between ages 3 and 17 years with American Society of Anesthesiology classification 1 or 2.

Exclusion Criteria:

• Children less than 3 years

• Children with uncorrected cardiac lesions

• Children with heart block or liver impairment

• Children with American Society of Anesthesiology Class 3 or 4.